tiprankstipranks
Trending News
More News >
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
Germany Market

Fresenius Medical Care AG & Co. KGaA (FME) Ratios

Compare
17 Followers

Fresenius Medical Care AG & Co. KGaA Ratios

DE:FME's free cash flow for Q3 2025 was €0.25. For the 2025 fiscal year, DE:FME's free cash flow was decreased by € and operating cash flow was €0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.36 1.40 1.42 1.27 1.10
Quick Ratio
1.00 1.03 1.07 0.91 0.82
Cash Ratio
0.22 0.20 0.23 0.20 0.20
Solvency Ratio
0.14 0.13 0.11 0.12 0.13
Operating Cash Flow Ratio
0.44 0.42 0.43 0.34 0.34
Short-Term Operating Cash Flow Coverage
4.62 4.13 2.78 1.59 1.29
Net Current Asset Value
€ -9.15B€ -9.88B€ -10.40B€ -12.10B€ -12.42B
Leverage Ratios
Debt-to-Assets Ratio
0.34 0.33 0.36 0.37 0.39
Debt-to-Equity Ratio
0.81 0.75 0.88 0.86 0.95
Debt-to-Capital Ratio
0.45 0.43 0.47 0.46 0.49
Long-Term Debt-to-Capital Ratio
0.33 0.30 0.34 0.32 0.32
Financial Leverage Ratio
2.39 2.30 2.49 2.31 2.46
Debt Service Coverage Ratio
3.08 2.94 1.92 1.68 1.35
Interest Coverage Ratio
3.86 3.42 3.22 -0.72 0.85
Debt to Market Cap
0.61 0.53 0.71 0.95 0.51
Interest Debt Per Share
37.18 38.81 42.52 46.28 46.67
Net Debt to EBITDA
2.93 3.07 3.63 3.71 3.46
Profitability Margins
Gross Profit Margin
25.00%24.60%25.32%27.37%28.82%
EBIT Margin
7.83%7.57%6.79%7.73%10.40%
EBITDA Margin
15.99%16.58%15.08%16.60%19.39%
Operating Profit Margin
7.60%7.20%7.04%-1.33%1.71%
Pretax Profit Margin
6.03%5.47%5.31%6.29%8.92%
Net Profit Margin
3.66%2.78%2.57%3.47%5.50%
Continuous Operations Profit Margin
4.62%3.83%3.14%4.61%6.92%
Net Income Per EBT
60.67%50.89%48.30%55.20%61.66%
EBT Per EBIT
79.31%75.91%75.43%-472.20%521.70%
Return on Assets (ROA)
2.33%1.60%1.47%1.88%2.82%
Return on Equity (ROE)
5.21%3.69%3.66%4.36%6.93%
Return on Capital Employed (ROCE)
5.94%4.99%4.92%-0.88%1.11%
Return on Invested Capital (ROIC)
4.36%3.35%3.30%-0.61%0.79%
Return on Tangible Assets
4.47%3.16%2.78%3.65%5.23%
Earnings Yield
6.49%4.15%4.48%7.51%5.79%
Efficiency Ratios
Receivables Turnover
6.00 4.93 4.79 5.21 4.92
Payables Turnover
17.81 14.81 19.06 14.80 14.63
Inventory Turnover
7.06 7.05 6.67 6.14 6.15
Fixed Asset Turnover
3.07 2.66 2.61 4.63 4.08
Asset Turnover
0.64 0.58 0.57 0.54 0.51
Working Capital Turnover Ratio
8.65 7.97 8.99 15.87 19.32
Cash Conversion Cycle
92.06 101.14 111.79 104.83 108.53
Days of Sales Outstanding
60.86 74.01 76.19 69.99 74.17
Days of Inventory Outstanding
51.70 51.77 54.75 59.49 59.31
Days of Payables Outstanding
20.49 24.64 19.15 24.65 24.96
Operating Cycle
112.55 125.79 130.94 129.49 133.48
Cash Flow Ratios
Operating Cash Flow Per Share
8.60 8.13 8.96 7.39 8.50
Free Cash Flow Per Share
6.09 5.75 6.63 2.58 2.75
CapEx Per Share
2.51 2.38 2.33 4.81 5.75
Free Cash Flow to Operating Cash Flow
0.71 0.71 0.74 0.35 0.32
Dividend Paid and CapEx Coverage Ratio
2.17 2.28 2.59 1.20 1.20
Capital Expenditure Coverage Ratio
3.43 3.41 3.84 1.54 1.48
Operating Cash Flow Coverage Ratio
0.24 0.22 0.22 0.16 0.19
Operating Cash Flow to Sales Ratio
0.13 0.12 0.14 0.11 0.14
Free Cash Flow Yield
15.98%13.02%17.46%8.43%4.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.50 24.09 22.32 13.31 17.27
Price-to-Sales (P/S) Ratio
0.57 0.67 0.57 0.46 0.95
Price-to-Book (P/B) Ratio
0.86 0.89 0.82 0.58 1.20
Price-to-Free Cash Flow (P/FCF) Ratio
6.29 7.68 5.73 11.86 20.77
Price-to-Operating Cash Flow Ratio
4.43 5.43 4.24 4.14 6.73
Price-to-Earnings Growth (PEG) Ratio
1.66 3.15 -0.86 -0.44 -1.05
Price-to-Fair Value
0.86 0.89 0.82 0.58 1.20
Enterprise Value Multiple
6.49 7.11 7.43 6.49 8.36
Enterprise Value
20.34B 22.79B 21.78B 20.90B 28.58B
EV to EBITDA
6.47 7.11 7.43 6.49 8.36
EV to Sales
1.04 1.18 1.12 1.08 1.62
EV to Free Cash Flow
11.44 13.51 11.21 27.65 35.46
EV to Operating Cash Flow
8.10 9.55 8.29 9.65 11.48
Tangible Book Value Per Share
-3.17 -2.63 -4.04 -6.35 -6.29
Shareholders’ Equity Per Share
44.33 49.68 46.42 52.68 47.72
Tax and Other Ratios
Effective Tax Rate
0.23 0.30 0.29 0.27 0.22
Revenue Per Share
67.25 65.90 66.30 66.15 60.14
Net Income Per Share
2.46 1.83 1.70 2.30 3.31
Tax Burden
0.61 0.51 0.48 0.55 0.62
Interest Burden
0.77 0.72 0.78 0.81 0.86
Research & Development to Revenue
<0.01 <0.01 0.01 0.01 0.01
SG&A to Revenue
0.09 0.12 0.12 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 >-0.01 <0.01
Income Quality
3.13 3.22 3.59 2.42 2.04
Currency in EUR